News Headlines Article

Melanoma treatment shows promise at UCSF
San Francisco Chronicle

The mole, a quarter-inch in diameter, had always marked David Amoroso’s forehead. But under the sun’s glare, it grew dark and jagged. By last spring, it had ballooned into a late-stage melanoma tumor.

Plagued with the deadliest form of skin cancer, the olive-skinned retired construction worker could have gone with the conventional route of drugs. But he feared they would have made him sick. Instead, the 72-year-old Woodside resident chose a treatment being tested in a small clinical trial by UCSF researchers.